Belgische Vereniging voor Inwendige Geneeskunde - Société belge de Médecine Interne - Belgian Society of Internal Medicine financials
A multi-period view of the public annual-account figures reported for Belgische Vereniging voor Inwendige Geneeskunde - Société belge de Médecine Interne - Belgian Society of Internal Medicine, with comparable measures and links to available source documents.
Company overviewRegistry number
0460965081
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 27, 2026
Financial evidence
Latest movements for Belgische Vereniging voor Inwendige Geneeskunde - Société belge de Médecine Interne - Belgian Society of Internal Medicine
2025 versus 2024
- Operating line
- €9,067
- EBITDA
- €9,067
- Total assets
- €229,678
- Equity
- €222,941
+587.7%
+587.7%
-4.4%
+4%
EBITDA margin +100% · Equity ratio +97.1%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €9,067 | €9,067 | €229,678 | €222,941 | - |
| 202431 Dec 2024 | €1,318 | €1,318 | €240,372 | €214,355 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.